VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study

2015/05/27 by Mikko Visuri, Mikko T. Visuri, Krista M. Honkonen +13
Medicine · #Lymphatic Disorders and Treatments #Lymphatic System and Diseases #Vascular Malformations and Hemangiomas

paper · doi:10.1007/s10456-015-9469-2

openalex publication_date 2015/05/27 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
• Immunohistochemical Expression of Endothelial Markers CD31, CD34, von Willebrand Factor, and Fli-1 in Normal Human Tissues
• Lymphedema